Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessandra Fabi

Showing results (191-200 of 265) with videos related to

Pageof 27
Sort By:
Frontiers in Oncology|February 21, 2022
Corrigendum: Results of the ECHO (Eating habits CHanges in Oncologic patients) Survey: An Italian Cross-Sectional Multicentric Study to Explore Dietary Changes and Dietary Supplement Use, in Breast Cancer SurvivorsGreta Caprara, Maria Tieri, Alessandra Fabi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2023
Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research studyAlessandro Rossi, Giacomo Aimar, Marco Audisio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2003
Addition of either lonidamine or granulocyte colony-stimulating factor does not improve survival in early breast cancer patients treated with high-dose epirubicin and cyclophosphamidePaola Papaldo, Massimo Lopez, Enrico Cortesi, et al.
Journal of Personalized Medicine|April 30, 2021
Neoadjuvant Chemotherapy in Breast Cancer: An Advanced Personalized Multidisciplinary Prehabilitation Model (APMP-M) to Optimize OutcomesAlba Di Leone, Daniela Terribile, Stefano Magno, et al.
Frontiers in Oncology|November 22, 2021
Results of the ECHO (Eating habits CHanges in Oncologic patients) Survey: An Italian Cross-Sectional Multicentric Study to Explore Dietary Changes and Dietary Supplement Use, in Breast Cancer SurvivorsGreta Caprara, Maria Tieri, Alessandra Fabi, et al.
Clinical Breast Cancer|November 19, 2019
T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational StudyBenedetta Conte, Alessandra Fabi, Francesca Poggio, et al.
Breast (Edinburgh, Scotland)|December 30, 2017
Human epidermal growth factor receptor 2 dual blockade with trastuzumab and pertuzumab in real life: Italian clinical practice versus the CLEOPATRA trial resultsSabino De Placido, Mario Giuliano, Francesco Schettini, et al.
Ecotoxicology and Environmental Safety|January 21, 2026
Chronic low-dose cadmium exposure accelerates the onset and metastasis of invasive mammary carcinoma and promotes immunosuppression in the tumor microenvironment in BALB-neuT miceChiara Focaccetti, Daniela Nardozi, Monica Benvenuto, et al.
Breast Cancer Research and Treatment|June 19, 2024
Male breast cancer: a multicenter study to provide a guide for proper managementGermana Lissidini, Luca Nicosia, Manuela Sargenti, et al.
Breast (Edinburgh, Scotland)|June 27, 2026
Dose-dense adjuvant chemotherapy in HER2-low breast cancer: An exploratory analysis of the GIM2 trialChiara Molinelli, Virginia Delucchi, Eva Blondeaux, et al.
Pageof 27

Showing results (191-200 of 265) with videos related to

Sort By:
Pageof 27
Frontiers in Oncology|February 21, 2022
Corrigendum: Results of the ECHO (Eating habits CHanges in Oncologic patients) Survey: An Italian Cross-Sectional Multicentric Study to Explore Dietary Changes and Dietary Supplement Use, in Breast Cancer SurvivorsGreta Caprara, Maria Tieri, Alessandra Fabi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 5, 2023
Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research studyAlessandro Rossi, Giacomo Aimar, Marco Audisio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 16, 2003
Addition of either lonidamine or granulocyte colony-stimulating factor does not improve survival in early breast cancer patients treated with high-dose epirubicin and cyclophosphamidePaola Papaldo, Massimo Lopez, Enrico Cortesi, et al.
Journal of Personalized Medicine|April 30, 2021
Neoadjuvant Chemotherapy in Breast Cancer: An Advanced Personalized Multidisciplinary Prehabilitation Model (APMP-M) to Optimize OutcomesAlba Di Leone, Daniela Terribile, Stefano Magno, et al.
Frontiers in Oncology|November 22, 2021
Results of the ECHO (Eating habits CHanges in Oncologic patients) Survey: An Italian Cross-Sectional Multicentric Study to Explore Dietary Changes and Dietary Supplement Use, in Breast Cancer SurvivorsGreta Caprara, Maria Tieri, Alessandra Fabi, et al.
Clinical Breast Cancer|November 19, 2019
T-DM1 Efficacy in Patients With HER2-positive Metastatic Breast Cancer Progressing After a Taxane Plus Pertuzumab and Trastuzumab: An Italian Multicenter Observational StudyBenedetta Conte, Alessandra Fabi, Francesca Poggio, et al.
Breast (Edinburgh, Scotland)|December 30, 2017
Human epidermal growth factor receptor 2 dual blockade with trastuzumab and pertuzumab in real life: Italian clinical practice versus the CLEOPATRA trial resultsSabino De Placido, Mario Giuliano, Francesco Schettini, et al.
Ecotoxicology and Environmental Safety|January 21, 2026
Chronic low-dose cadmium exposure accelerates the onset and metastasis of invasive mammary carcinoma and promotes immunosuppression in the tumor microenvironment in BALB-neuT miceChiara Focaccetti, Daniela Nardozi, Monica Benvenuto, et al.
Breast Cancer Research and Treatment|June 19, 2024
Male breast cancer: a multicenter study to provide a guide for proper managementGermana Lissidini, Luca Nicosia, Manuela Sargenti, et al.
Breast (Edinburgh, Scotland)|June 27, 2026
Dose-dense adjuvant chemotherapy in HER2-low breast cancer: An exploratory analysis of the GIM2 trialChiara Molinelli, Virginia Delucchi, Eva Blondeaux, et al.
Pageof 27